What is Zentek?
Zentek operates as a specialized intellectual property development and commercialization firm, primarily targeting the healthcare landscape. The company's core value proposition centers on the deployment of ZenGUARD, a patent-pending antimicrobial coating that has demonstrated significant efficacy in neutralizing pathogens, including those associated with COVID-19. Beyond surface protection, Zentek is expanding its operational footprint through an exclusive global partnership for aptamer-based rapid pathogen detection technology. By bridging the gap between laboratory-stage innovation and market-ready healthcare solutions, Zentek addresses critical gaps in disease prevention, detection, and treatment protocols. Its business model relies on the strategic licensing and distribution of high-barrier-to-entry technologies, ensuring a competitive advantage in the global health security market.
How much funding has Zentek raised?
Zentek has raised a total of $1.8M across 1 funding round:
Stock/Share Issuance
$1.8M
Stock/Share Issuance (2026): $1.8M, investors not publicly disclosed
Key Investors in Zentek
Zentek
Undisclosed investor participating in the funding round.
What's next for Zentek?
With the infusion of this major enterprise-level funding, Zentek is poised to transition from a development-focused entity to a commercial powerhouse. The strategic roadmap likely involves scaling the manufacturing and distribution of ZenGUARD to meet industrial and clinical demand. Furthermore, the company is expected to prioritize the regulatory approval and market rollout of its aptamer-based detection systems. As the firm leverages its recent capital, stakeholders should anticipate increased investment in clinical validation studies and the expansion of its global commercialization network. This phase of growth will be critical in establishing Zentek as a foundational provider of next-generation infectious disease mitigation tools, potentially setting the stage for further market penetration and long-term value creation in the biotechnology and public health sectors.
See full Zentek company page
